McKessonMCK
Distribution & pharmacy infrastructure · NYSE · USA
Up 11.0% this year and +21.8% since June 26, ahead of the life science sector at +10.7%. McKesson supplies 1 mapped company and buys from 10.
Suppliers 10
- JNJJohnson & Johnson−0.8%
- BMYBristol Myers Squibb−0.2%
- ABBVAbbVie+0.4%
- VRTXVertex Pharmaceuticals−0.5%
- GILDGilead Sciences+0.2%
- BIIBBiogen−1.7%
- NBIXNeurocrine Biosciences−1.5%
- LLYEli Lilly−1.6%
- PFEPfizer−0.6%
- MRKMerck & Co.−0.3%
Customers 1
About McKesson
Medicines reach the counter through wholesalers, and McKesson is one of them: its customers run from pharmacies to hospitals and clinics across the US. Alongside distribution it sells services to pharmacy operators and runs an oncology network.
Theme exposure
Products
- Drug distribution
- Pharmacy services
- Oncology network
Competitors
Risks
- Low-margin business
- Opioid-related settlements
Same segment: Distribution & pharmacy infrastructure
Wholesalers, distribution and pharmacy chains that get medicines to patients. Segment 8 of 8 in the Medicine, pharma & life science value chain.
Compare MCK
Side by side with the largest companies in the same segment.
See where McKesson sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.
Open the Life science value chain →